Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
OBI’s LANTERN Phase 3 study met its primary endpoint, reporting a 40.5% reduction in 30-day surgical site infections with nasal photodisinfection added to standard care. The study cites robust Bayesian and frequentist analyses and a strong safety profile.
OBI’s LANTERN Phase III study met its primary endpoint, with a 40.5% reduction in 30-day surgical site infections after adding nasal photodisinfection to standard care. The report says analyses supported the result and that the intervention showed a strong safety profile.